Evolving molecular subtyping of breast cancer advances precision treatment

Cancer Biol Med. 2024 Sep 19;21(9):j.issn.2095-3941.2024.0222. doi: 10.20892/j.issn.2095-3941.2024.0222.

Authors

Rui Shan^#^{1

2}, Lei-Jie Dai^#^{1

2}, Zhi-Ming Shao^{1

2}, Yi-Zhou Jiang^{1

2}

Affiliations

¹ Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
² Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China.

^# Contributed equally.

PMID: 39302031
DOI: 10.20892/j.issn.2095-3941.2024.0222

No abstract available

Publication types

Editorial

MeSH terms

Biomarkers, Tumor / genetics
Breast Neoplasms* / genetics
Breast Neoplasms* / pathology
Breast Neoplasms* / therapy
Female
Humans
Precision Medicine* / methods

Substances

Biomarkers, Tumor